1.Metachronous Gastric MALT Lymphoma and Early Gastric Cancer: A Case Report.
Dong Beom SEO ; Kye Sook KWON ; Hyun Shin PARK ; Don Haeng LEE ; Hyung Gil KIM ; Yong Woon SHIN ; Young Soo KIM ; Joon Mi KIM
The Korean Journal of Gastroenterology 2007;49(4):245-250
Metachronous association between gastric lymphoma and early gastric cancer is a rare event. Recent studies have suggested that a relationship exists between gastric mucosa-associated lymphoid tissue (MALT) lymphoma and gastric carcinoma although the mechanism is unknown. Herein, we report a 53-year-old man who visited to our hospital due to melena. Esophagogastroduodenoscopy (EGD) revealed a MALT lymphoma on the greater curvature of lower body. The patient received anti-Helicobacter pylori eradication therapy, followed by 6 cycles of chemotherapy and radiation therapy, and achieved complete remission 12 months after the therapy. Three years later, he revisited our hospital with epigastric pain. EGD revealed an early gastric cancer on the anterior wall of proximal antrum, nearly opposite to the previous lymphoma site, and a partial gastrectomy was performed. To the best of our knowledge, this is the first case report of metachronous MALT lymphoma and subsequent gastric carcinoma in Korea.
Anti-Bacterial Agents/therapeutic use
;
Endoscopy, Digestive System
;
Gastric Mucosa/*pathology
;
Helicobacter Infections/drug therapy
;
Helicobacter pylori
;
Humans
;
Lymphoma, B-Cell, Marginal Zone/*diagnosis/pathology/radiotherapy
;
Male
;
Middle Aged
;
Neoplasms, Second Primary/*diagnosis/etiology
;
Stomach Neoplasms/*diagnosis/pathology
2.Four Cases of Hematologic Malignancy Following Radioactive Iodine Therapy for Thyroid Cancer.
Mijeong IM ; Jin Kyung LEE ; Young Joon HONG ; Seok Il HONG ; Hye Jin KANG ; Im Il NA ; Baek Yeol RYOO ; Gi Jeong CHEON ; Ha Na LEE ; Yoon Hwan CHANG
The Korean Journal of Laboratory Medicine 2008;28(6):425-429
Ionizing radiation including I131 might produce chromosomal translocation, causing hematologic malignancy. The incidence of leukemia following radioactive iodine treatment for thyroid cancer has been reported to be approximately 0.1 to 2.0% in Western countries, whereas fewer cases have been reported in Korea. We hereby report four cases of secondary hematologic malignancy, who received iodine therapy for thyroid cancer after thyroidectomy: two cases of acute lymphoblastic leukemia with t(9;22)(q34;q11.2), a case of MDS with 5q deletion, and a case of MDS with normal karyotype. Three cases of hematologic malignancy have developed after cumulative dosage of less than 800 mCi. The treatment intervals in two cases were less than 12 months, and the other two cases had I131 therapy only once. Assessment of causality using the Naranjo probability scale for adverse drug reactions showed that a 'possible' relationship existed between the use of I131 and secondary hematologic malignancy in all of the four cases in this report.
Adult
;
Chromosomes, Human, Pair 22
;
Chromosomes, Human, Pair 5
;
Chromosomes, Human, Pair 9
;
Female
;
Gene Deletion
;
Hematologic Neoplasms/*diagnosis/genetics
;
Humans
;
Iodine Radioisotopes/*adverse effects/therapeutic use
;
Leukemia, Radiation-Induced/*diagnosis/etiology
;
Middle Aged
;
Myelodysplastic Syndromes/diagnosis/genetics
;
Neoplasms, Second Primary/*diagnosis/genetics
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/genetics
;
Thyroid Neoplasms/*radiotherapy
;
Thyroidectomy
;
Translocation, Genetic
3.Development of Acute Megakaryoblastic Leukemia with Isochromosome (12p) after a Primary Mediastinal Germ Cell Tumor in Korea.
Nae YU ; Hye Ryoun KIM ; Young Joo CHA ; Eun Kyung PARK ; Jeong Wook KIM
Journal of Korean Medical Science 2011;26(8):1099-1102
The association of hematological malignancies with a mediastinal germ cell tumor (GCT) is very rare. We report one case of a young adult male with primary mediastinal GCT who subsequently developed acute megakaryoblastic leukemia involving isochromosome (12p). A 25-yr-old man had been diagnosed with a mediastinal GCT and underwent surgical resection and adjuvant chemotherapy. At 1 week after the last cycle of chemotherapy, his peripheral blood showed leukocytosis with blasts. A bone marrow study confirmed the acute megakaryoblastic leukemia. A cytogenetic study revealed a complex karyotype with i(12p). Although additional chemotherapy was administered, the patient could not attain remission and died of septic shock. This case was definitely distinct from therapy-related secondary leukemia in terms of clinical, morphologic, and cytogenetic features. To our knowledge, this is the first case report of a patient with mediastinal GCT subsequently developing acute megakaryoblastic leukemia involving i(12p) in Korea.
Adult
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Bleomycin/administration & dosage
;
Bone Marrow/pathology
;
*Chromosomes, Human, Pair 12
;
Cisplatin/administration & dosage
;
Etoposide/administration & dosage
;
Humans
;
Isochromosomes
;
Karyotyping
;
Leukemia, Megakaryoblastic, Acute/drug therapy/etiology/*genetics
;
Male
;
Mediastinal Neoplasms/*diagnosis/drug therapy/surgery
;
Neoplasms, Germ Cell and Embryonal/*diagnosis/drug therapy/surgery
;
Neoplasms, Second Primary/drug therapy/etiology/*genetics
;
Republic of Korea
;
Shock, Septic/pathology
4.Therapy-Related Myeloid Neoplasms in 39 Korean Patients: A Single Institution Experience.
Hee Jae HUH ; Soo Hyun LEE ; Keon Hee YOO ; Ki Woong SUNG ; Hong Hoe KOO ; Kihyun KIM ; Jun Ho JANG ; Chulwon JUNG ; Sun Hee KIM ; Hee Jin KIM
Annals of Laboratory Medicine 2013;33(2):97-104
BACKGROUND: Therapy-related myeloid neoplasms (t-MN) occur as late complications of cytotoxic therapy. This study reviewed clinical and cytogenetic characteristics of patients with t-MN at a single institution in Korea. METHODS: The study subjects included 39 consecutive patients diagnosed with t-MN. Each subject's clinical history of previous diseases, treatments, and laboratory data was reviewed, including cytogenetics. The primary diagnosis was hematologic malignancy in 14 patients and solid tumor in 25 patients. RESULTS: Therapy-related acute myeloid leukemia (t-AML, 66.7%) was found to be more common than therapy-related myelodysplastic syndrome (t-MDS). Primary hematologic malignancies that were commonly implicated included mature B-cell neoplasm and acute leukemia. Breast cancer was the most common primary solid tumor. The mean time interval from cytotoxic therapy initiation to t-MN detection was 49 months. Chromosomal aberrations were observed in 35 patients, and loss of chromosome 5, 7, or both accounted for 41% of all cases. Balanced rearrangements occurred in 13 patients; these patients showed shorter latency intervals (mean, 38 months) than patients with loss of chromosome 5 or 7 (mean, 61 months). CONCLUSIONS: In this study, we determined the clinical and cytogenetic characteristics of Korean patients with t-MN. Although our results were generally consistent with those of previous reports, we found that t-MN resulting from de novo leukemia was common and that t-AML was more common than t-MDS at presentation. Multi-institutional studies involving a larger number of patients and additional parameters are required to investigate the epidemiology, genetic predisposition, and survival rate of t-MN in Korea.
Adolescent
;
Adult
;
Aged
;
Antineoplastic Agents/*adverse effects/therapeutic use
;
Asian Continental Ancestry Group
;
Bone Marrow/pathology
;
Breast Neoplasms/drug therapy/pathology/radiotherapy
;
Child
;
Child, Preschool
;
Chromosome Aberrations
;
Chromosomes, Human, Pair 5
;
Chromosomes, Human, Pair 7
;
Female
;
Hematologic Neoplasms/drug therapy/pathology/radiotherapy
;
Humans
;
Karyotyping
;
Leukemia, Myeloid, Acute/*diagnosis/etiology/genetics
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes/*diagnosis/etiology/genetics
;
Neoplasms, Second Primary/*diagnosis/etiology/genetics
;
Republic of Korea
;
Young Adult